Alzheimer's amyloid peptides mediate hypoxic up-regulation of L-type Ca2+ channels.
about
α7 nicotinic ACh receptors as a ligand-gated source of Ca(2+) ions: the search for a Ca(2+) optimumGenetic interactions found between calcium channel genes modulate amyloid load measured by positron emission tomography.Multiple oxygen tension environments reveal diverse patterns of transcriptional regulation in primary astrocytes.L-type voltage-gated calcium channel blockade with isradipine as a therapeutic strategy for Alzheimer's diseaseRole of KATP and L-type Ca2+ channel activities in regulation of ovine uterine vascular contractility: effect of pregnancy and chronic hypoxia.Short- and long-term treatment of mouse cortical primary astrocytes with β-amyloid differentially regulates the mRNA expression of L-type calcium channels.CaV1.2 calcium channel expression in reactive astrocytes is associated with the formation of amyloid-β plaques in an Alzheimer's disease mouse model.A translational continuum of model systems for evaluating treatment strategies in Alzheimer's disease: isradipine as a candidate drug.Reduction in neuronal L-type calcium channel activity in a double knock-in mouse model of Alzheimer's disease.Mitochondrial dysfunction in skeletal muscle of amyloid precursor protein-overexpressing mice.A central role for ROS in the functional remodelling of L-type Ca2+ channels by hypoxiaThe role of beta-amyloid protein in synaptic function: implications for Alzheimer's disease therapy.The changing landscape of voltage-gated calcium channels in neurovascular disorders and in neurodegenerative diseasesEffects of amyloid-β peptides on voltage-gated L-type Ca(V)1.2 and Ca(V)1.3 Ca(2+) channelsDanger: High Voltage-The Role of Voltage-Gated Calcium Channels in Central Nervous System Pathology.
P2860
Q26852967-9E4724FE-BBD8-4B2F-9BAB-B5DD647B70A4Q33709603-A739EF80-BFD6-47CF-BBC0-AE728103B9B7Q33955205-76E4BAC6-10A3-4E82-BBC8-91D4D75BDDFCQ34135977-2C1C1502-5778-49E2-86E5-E56527ED05C3Q34361543-7B11E3FE-AEBE-47BA-8F09-B3977526E5B7Q35028876-F740DBCA-C7D3-448C-AEFB-6A4055100FABQ35034581-63EC4DB1-20F0-4BE5-A8F4-CA5191077419Q35232631-062B01F8-EA88-4D04-BABF-435C34D9B390Q35802779-76754E5D-8917-41CF-9C43-CEAED9521E3EQ36016957-75B1772D-2AA0-4F45-A653-DD1CC8788BB5Q36328351-112DB97A-94EF-49F9-AF37-412B0DEEA8EBQ37211751-99675BCA-75E4-4614-B63F-FD7EE58019B5Q38157892-1C0A62CA-D61A-4D9B-B70E-DE58224C0957Q41864180-18ACC6A8-573F-498B-8BA9-8B42743B5826Q47838572-B4268EFC-7B4C-4805-BABA-24463AA3F32C
P2860
Alzheimer's amyloid peptides mediate hypoxic up-regulation of L-type Ca2+ channels.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Alzheimer's amyloid peptides mediate hypoxic up-regulation of L-type Ca2+ channels.
@en
Alzheimer's amyloid peptides mediate hypoxic up-regulation of L-type Ca2+ channels.
@en-gb
type
label
Alzheimer's amyloid peptides mediate hypoxic up-regulation of L-type Ca2+ channels.
@en
Alzheimer's amyloid peptides mediate hypoxic up-regulation of L-type Ca2+ channels.
@en-gb
prefLabel
Alzheimer's amyloid peptides mediate hypoxic up-regulation of L-type Ca2+ channels.
@en
Alzheimer's amyloid peptides mediate hypoxic up-regulation of L-type Ca2+ channels.
@en-gb
P2093
P50
P356
P1433
P1476
Alzheimer's amyloid peptides mediate hypoxic up-regulation of L-type Ca2+ channels.
@en
P2093
Gyula Varadi
Ian M Fearon
Stephen G Ball
P304
P356
10.1096/FJ.04-2659FJE
P407
P577
2004-10-19T00:00:00Z